Emerging role of CaMKII in neuropsychiatric disease

Trends in Neurosciences

Volumn 37, Issue 11, 2014, Pages 653-662

  Robison, A J ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Addiction; CaMKII; Depression; Epilepsy; Psychiatric disease; Schizophrenia

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; GLUTAMIC ACID;

BRAIN REGION; DEPRESSION; DEVELOPMENTAL DISORDER; DRUG DEPENDENCE; EPILEPSY; HUMAN; MENTAL DISEASE; MOLECULAR PATHOLOGY; NERVE CELL PLASTICITY; NEUROLOGIC DISEASE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW; SCHIZOPHRENIA; SIGNAL TRANSDUCTION; ANIMAL; BRAIN; METABOLISM; NERVE CELL; PHYSIOLOGY; PSYCHOLOGY;

ANIMALS; BRAIN; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE TYPE 2; EPILEPSY; HUMANS; NEURONAL PLASTICITY; NEURONS; SIGNAL TRANSDUCTION;

EID: 84909965363     PISSN: 01662236     EISSN: 1878108X     Source Type: Journal    
DOI: 10.1016/j.tins.2014.07.001     Document Type: Review

References (127)

1. Nestler E.J., et al. Molecular Neuropharmacology: A Foundation for Clinical Neuroscience 2009, McGraw-Hill Medical.
2. Colbran R.J., Brown A.M. Calcium/calmodulin-dependent protein kinase II and synaptic plasticity. Curr. Opin. Neurobiol. 2004, 14:318-327.
3. Coultrap S.J., Bayer K.U. CaMKII regulation in information processing and storage. Trends Neurosci. 2012, 35:607-618.
4. 2+/calmodulin-dependent protein kinase II. Biochem. J. 2002, 364:593-611.
5. 2+/calmodulin dependent protein kinase II. Curr. Opin. Struct. Biol. 2013, 23:292-301.
6. 2+/CaM-stimulated CaMKII activity. PLoS ONE 2012, 7:e37176.
7. 2+ oscillations. Science 1998, 279:227-230.
8. Colbran R.J., Soderling T.R. Calcium/calmodulin-independent autophosphorylation sites of calcium/calmodulin-dependent protein kinase II. Studies on the effect of phosphorylation of threonine 305/306 and serine 314 on calmodulin binding using synthetic peptides. J. Biol. Chem. 1990, 265:11213-11219.
9. Luczak E.D., Anderson M.E. CaMKII oxidative activation and the pathogenesis of cardiac disease. J. Mol. Cell. Cardiol. 2014, 73:112-116.
10. Sanders P.N., et al. CaMKII is essential for the proasthmatic effects of oxidation. Sci. Transl. Med. 2013, 5:195ra197.
11. Klug J.R., et al. Genetic inhibition of CaMKII in dorsal striatal medium spiny neurons reduces functional excitatory synapses and enhances intrinsic excitability. PLoS ONE 2012, 7:e45323.
12. 2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. J. Neurosci. 2004, 24:5283-5291.
13. Silva A.J., et al. Deficient hippocampal long-term potentiation in alpha-calcium-calmodulin kinase II mutant mice. Science 1992, 257:201-206.
14. Silva A.J., et al. Impaired spatial learning in alpha-calcium-calmodulin kinase II mutant mice. Science 1992, 257:206-211.
15. Fang L., et al. Calcium-calmodulin-dependent protein kinase II contributes to spinal cord central sensitization. J. Neurosci. 2002, 22:4196-4204.
16. Hell J.W. CaMKII: claiming center stage in postsynaptic function and organization. Neuron 2014, 81:249-265.
17. 2+/calmodulin protein kinase IIalpha (CaMKIIalpha) to inhibitory synapses. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:20559-20564.
18. Robinson T.E., Berridge K.C. The incentive sensitization theory of addiction: some current issues. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2008, 363:3137-3146.
19. Kauer J.A., Malenka R.C. Synaptic plasticity and addiction. Nat. Rev. Neurosci. 2007, 8:844-858.
20. Robison A.J., Nestler E.J. Transcriptional and epigenetic mechanisms of addiction. Nat. Rev. Neurosci. 2011, 12:623-637.
21. Kalivas P.W. The glutamate homeostasis hypothesis of addiction. Nat. Rev. Neurosci. 2009, 10:561-572.
22. Anderson S.M., et al. CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking. Nat. Neurosci. 2008, 11:344-353.
23. 2+/calmodulin-dependent protein kinase II in the nucleus accumbens shell enhances behavioral responding to amphetamine. J. Neurosci. 2010, 30:939-949.
24. Robison A.J., et al. Behavioral and structural responses to chronic cocaine require a feedforward loop involving δFosB and calcium/calmodulin-dependent protein kinase II in the nucleus accumbens shell. J. Neurosci. 2013, 33:4295-4307.
25. Wang L., et al. Chronic cocaine-induced H3 acetylation and transcriptional activation of CaMKIIalpha in the nucleus accumbens is critical for motivation for drug reinforcement. Neuropsychopharmacology 2010, 35:913-928.
26. Loweth J.A., et al. Inhibition of CaMKII in the nucleus accumbens shell decreases enhanced amphetamine intake in sensitized rats. Neurosci. Lett. 2008, 444:157-160.
27. Pierce R.C., et al. Calcium-mediated second messengers modulate the expression of behavioral sensitization to cocaine. J. Pharmacol. Exp. Ther. 1998, 286:1171-1176.
28. Kourrich S., et al. AMPAR-independent effect of striatal alphaCaMKII promotes the sensitization of cocaine reward. J. Neurosci. 2012, 32:6578-6586.
29. Dong Y., et al. CREB modulates excitability of nucleus accumbens neurons. Nat. Neurosci. 2006, 9:475-477.
30. Thomas M.J., et al. Long-term depression in the nucleus accumbens: a neural correlate of behavioral sensitization to cocaine. Nat. Neurosci. 2001, 4:1217-1223.
31. Thomas M.J., Malenka R.C. Synaptic plasticity in the mesolimbic dopamine system. Philos. Trans. R. Soc. Lond. B: Biol. Sci. 2003, 358:815-819.
32. Kourrich S., et al. Cocaine experience controls bidirectional synaptic plasticity in the nucleus accumbens. J. Neurosci. 2007, 27:7921-7928.
33. Boudreau A.C., Wolf M.E. Behavioral sensitization to cocaine is associated with increased AMPA receptor surface expression in the nucleus accumbens. J. Neurosci. 2005, 25:9144-9151.
34. Liu X., et al. CaMKII activity in the ventral tegmental area gates cocaine-induced synaptic plasticity in the nucleus accumbens. Neuropsychopharmacology 2014, 39:989-999.
35. Argilli E., et al. Mechanism and time course of cocaine-induced long-term potentiation in the ventral tegmental area. J. Neurosci. 2008, 28:9092-9100.
36. Iwata S.I., et al. Enhanced dopamine release and phosphorylation of synapsin I and neuromodulin in striatal synaptosomes after repeated amphetamine. J. Pharmacol. Exp. Ther. 1997, 283:1445-1452.
37. Easton A.C., et al. αCaMKII autophosphorylation controls the establishment of alcohol drinking behavior. Neuropsychopharmacology 2013, 38:1636-1647.
38. Easton A.C., et al. αCaMKII autophosphorylation controls the establishment of alcohol-induced conditioned place preference in mice. Behav. Brain Res. 2013, 252:72-76.
39. Easton A.C., et al. αCaMKII autophosphorylation controls exploratory activity to threatening novel stimuli. Neuropharmacology 2011, 61:1424-1431.
40. Charney D.S., Nestler E.J. Neurobiology of Mental Illness 2009, Oxford University Press.
41. Sanacora G., et al. Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders. Neuropharmacology 2012, 62:63-77.
42. Trullas R., Skolnick P. Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. Eur. J. Pharmacol. 1990, 185:1-10.
43. Pittenger C., Duman R.S. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008, 33:88-109.
44. Marsden W.N. Synaptic plasticity in depression: molecular, cellular and functional correlates. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 43:168-184.
45. Matsumoto M., Hikosaka O. Lateral habenula as a source of negative reward signals in dopamine neurons. Nature 2007, 447:1111-1115.
46. Lammel S., et al. Input-specific control of reward and aversion in the ventral tegmental area. Nature 2012, 491:212-217.
47. Li K., et al. betaCaMKII in lateral habenula mediates core symptoms of depression. Science 2013, 341:1016-1020.
48. Ji H., Shepard P.D. Lateral habenula stimulation inhibits rat midbrain dopamine neurons through a GABA(A) receptor-mediated mechanism. J. Neurosci. 2007, 27:6923-6930.
49. Fowler C.D., et al. Habenular alpha5 nicotinic receptor subunit signalling controls nicotine intake. Nature 2011, 471:597-601.
50. Robison A.J., et al. Fluoxetine epigenetically alters the CaMKIIα promoter in nucleus accumbens to regulate δFosB binding and antidepressant effects. Neuropsychopharmacology 2014, 39:1178-1186.
51. Cai X., et al. Local potentiation of excitatory synapses by serotonin and its alteration in rodent models of depression. Nat. Neurosci. 2013, 16:464-472.
52. Xing G., et al. Decreased prefrontal CaMKII alpha mRNA in bipolar illness. Neuroreport 2002, 13:501-505.
53. Wen Y., et al. Dysfunction of calcium/calmodulin/CaM kinase IIalpha cascades in the medial prefrontal cortex in post-traumatic stress disorder. Mol. Med. Rep. 2012, 6:1140-1144.
54. McReynolds J.R., McIntyre C.K. Emotional modulation of the synapse. Rev. Neurosci. 2012, 23:449-461.
55. Laruelle M. Schizophrenia: from dopaminergic to glutamatergic interventions. Curr. Opin. Pharmacol. 2014, 14:97-102.
56. Egerton A., Stone J.M. The glutamate hypothesis of schizophrenia: neuroimaging and drug development. Curr. Pharm. Biotechnol. 2012, 13:1500-1512.
57. Moghaddam B., Javitt D. From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment. Neuropsychopharmacology 2012, 37:4-15.
58. Luby E.D., et al. Model psychoses and schizophrenia. Am. J. Psychiatry 1962, 119:61-67.
59. Begni S., et al. Association between the G1001C polymorphism in the GRIN1 gene promoter region and schizophrenia. Biol. Psychiatry 2003, 53:617-619.
60. Martucci L., et al. N-methyl-D-aspartate receptor NR2B subunit gene GRIN2B in schizophrenia and bipolar disorder: polymorphisms and mRNA levels. Schizophr. Res. 2006, 84:214-221.
61. Javitt D.C. Glutamate and schizophrenia: phencyclidine, N-methyl-D-aspartate receptors, and dopamine-glutamate interactions. Int. Rev. Neurobiol. 2007, 78:69-108.
62. Yamasaki N., et al. Alpha-CaMKII deficiency causes immature dentate gyrus, a novel candidate endophenotype of psychiatric disorders. Mol. Brain 2008, 1:6.
63. Miyakawa T., et al. Conditional calcineurin knockout mice exhibit multiple abnormal behaviors related to schizophrenia. Proc. Natl. Acad. Sci. U.S.A. 2003, 100:8987-8992.
64. Shin R., et al. The immature dentate gyrus represents a shared phenotype of mouse models of epilepsy and psychiatric disease. Bipolar Disord. 2013, 15:405-421.
65. Walton N.M., et al. Detection of an immature dentate gyrus feature in human schizophrenia/bipolar patients. Transl. Psychiatry 2012, 2:e135.
66. Harrison P.J. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications. Psychopharmacology (Berl.) 2004, 174:151-162.
67. Strack S., et al. Association of calcium/calmodulin-dependent kinase II with developmentally regulated splice variants of the postsynaptic density protein densin-180. J. Biol. Chem. 2000, 275:25061-25064.
68. Robison A.J., et al. Multivalent interactions of calcium/calmodulin-dependent protein kinase II with the postsynaptic density proteins NR2B, densin-180, and alpha-actinin-2. J. Biol. Chem. 2005, 280:35329-35336.
69. 2+/calmodulin-dependent protein kinase II and α-actinin. J. Neurosci. 2001, 21:423-433.
70. Carlisle H.J., et al. Deletion of densin-180 results in abnormal behaviors associated with mental illness and reduces mGluR5 and DISC1 in the postsynaptic density fraction. J. Neurosci. 2011, 31:16194-16207.
71. Halt A.R., et al. CaMKII binding to GluN2B is critical during memory consolidation. EMBO J. 2012, 31:1203-1216.
72. During M.J., Spencer D.D. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 1993, 341:1607-1610.
73. + and the glutamate/GABA hypotheses of epilepsy. Epilepsy Res. 2014, 108:995-1012.
74. Rogawski M.A. AMPA receptors as a molecular target in epilepsy therapy. Acta Neurol. Scand. 2013, 127(Suppl. s197):9-18.
75. Liu X.B., Murray K.D. Neuronal excitability and calcium/calmodulin-dependent protein kinase type II: location, location, location. Epilepsia 2012, 53(Suppl. 1):45-52.
76. Wasterlain C.G., Farber D.B. Kindling alters the calcium/calmodulin-dependent phosphorylation of synaptic plasma membrane proteins in rat hippocampus. Proc. Natl. Acad. Sci. U.S.A. 1984, 81:1253-1257.
77. Goldenring J.R., et al. Kindling induces a long-lasting change in the activity of a hippocampal membrane calmodulin-dependent protein kinase system. Brain Res. 1986, 377:47-53.
78. 2+/calmodulin-dependent protein kinase II during prolonged seizure activity and its consequence after the recovery from seizure activity in rats in vivo. Neuroscience 2006, 140:981-992.
79. 2+/calmodulin dependent protein kinase II dephosphorylation and subcellular distribution in rat brain for several hours. Neurosci. Lett. 2004, 357:95-98.
80. 2+/calmodulin-dependent protein kinase II after a brief pentylenetetrazol seizure; potential role in kindling. Epilepsy Res. 2004, 58:107-117.
81. 2+/calmodulin-dependent kinase II alpha-subunit mutation. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:6852-6855.
82. Wei J., et al. Phosphorylation and inhibition of type III adenylyl cyclase by calmodulin-dependent protein kinase II in vivo. J. Biol. Chem. 1996, 271:24231-24235.
83. 2+/calmodulin-dependent protein kinase. J. Neurosci. 1997, 17:3379-3391.
84. Thibert R.L., et al. Neurologic manifestations of Angelman syndrome. Pediatr. Neurol. 2013, 48:271-279.
85. Jana N.R. Understanding the pathogenesis of Angelman syndrome through animal models. Neural Plast. 2012, 2012:710943.
86. Pignatelli M., et al. Changes in mGlu5 receptor-dependent synaptic plasticity and coupling to homer proteins in the hippocampus of Ube3A hemizygous mice modeling angelman syndrome. J. Neurosci. 2014, 34:4558-4566.
87. Mizutani A., et al. Phosphorylation of Homer3 by calcium/calmodulin-dependent kinase II regulates a coupling state of its target molecules in Purkinje cells. J. Neurosci. 2008, 28:5369-5382.
88. Huang C.C., Hsu K.S. Activation of NMDA receptors reduces metabotropic glutamate receptor-induced long-term depression in the nucleus accumbens via a CaMKII-dependent mechanism. Neuropharmacology 2012, 63:1298-1307.
89. Weeber E.J., et al. Derangements of hippocampal calcium/calmodulin-dependent protein kinase II in a mouse model for Angelman mental retardation syndrome. J. Neurosci. 2003, 23:2634-2644.
90. Dindot S.V., et al. The Angelman syndrome ubiquitin ligase localizes to the synapse and nucleus, and maternal deficiency results in abnormal dendritic spine morphology. Hum. Mol. Genet. 2008, 17:111-118.
91. van Woerden G.M., et al. Rescue of neurological deficits in a mouse model for Angelman syndrome by reduction of alphaCaMKII inhibitory phosphorylation. Nat. Neurosci. 2007, 10:280-282.
92. 2+/calmodulin-dependent protein kinase IIα (αCaMKII) controls the activity of the dopamine transporter: implications for Angelman syndrome. J. Biol. Chem. 2012, 287:29627-29635.
93. Cao C., et al. Impairment of TrkB-PSD-95 signaling in Angelman syndrome. PLoS Biol. 2013, 11:e1001478.
94. Daily J.L., et al. Adeno-associated virus-mediated rescue of the cognitive defects in a mouse model for Angelman syndrome. PLoS ONE 2011, 6:e27221.
95. Singer B.F., et al. Transient viral-mediated overexpression of alpha-calcium/calmodulin-dependent protein kinase II in the nucleus accumbens shell leads to long-lasting functional upregulation of alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate receptors: dopamine type-1 receptor and protein kinase A dependence. Eur. J. Neurosci. 2010, 31:1243-1251.
96. Loweth J.A., et al. Persistent reversal of enhanced amphetamine intake by transient CaMKII inhibition. J. Neurosci. 2013, 33:1411-1416.
97. Sidorov M.S., et al. Fragile X mental retardation protein and synaptic plasticity. Mol. Brain 2013, 6:15.
98. Weiler I.J., et al. Fragile X mental retardation protein is translated near synapses in response to neurotransmitter activation. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:5395-5400.
99. Martin B.S., Huntsman M.M. Pathological plasticity in fragile X syndrome. Neural Plast. 2012, 2012:275630.
100. Mayford M., et al. The 3'-untranslated region of CaMKII alpha is a cis-acting signal for the localization and translation of mRNA in dendrites. Proc. Natl. Acad. Sci. U.S.A. 1996, 93:13250-13255.
101. Benson D.L., et al. Dendritic localization of type II calcium calmodulin-dependent protein kinase mRNA in normal and reinnervated rat hippocampus. Neuroscience 1992, 46:851-857.
102. El Fatimy R., et al. Fragile X mental retardation protein interacts with the RNA-binding protein Caprin1 in neuronal ribonucleoprotein complexes. PLoS ONE 2012, 7:e39338.
103. Sudhakaran I.P., et al. FMRP and Ataxin-2 function together in long-term olfactory habituation and neuronal translational control. Proc. Natl. Acad. Sci. U.S.A. 2014, 111:E99-E108.
104. Zachariah R.M., Rastegar M. Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research. Neural Plast. 2012, 2012:415825.
105. Nguyen M.V., et al. MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain. J. Neurosci. 2012, 32:10021-10034.
106. Lisman J., et al. Mechanisms of CaMKII action in long-term potentiation. Nat. Rev. Neurosci. 2012, 13:169-182.
107. Giese K.P., et al. Autophosphorylation at Thr286 of the alpha calcium-calmodulin kinase II in LTP and learning. Science 1998, 279:870-873.
108. 2+/calmodulin-dependent protein kinase II regulatory phosphorylation site in the alpha-amino-3-hydroxyl-5-methyl-4-isoxazole-propionate-type glutamate receptor. J. Biol. Chem. 1997, 272:32727-32730.
109. Hayashi Y., et al. Driving AMPA receptors into synapses by LTP and CaMKII: requirement for GluR1 and PDZ domain interaction. Science 2000, 287:2262-2267.
110. Shen K., Meyer T. Dynamic control of CaMKII translocation and localization in hippocampal neurons by NMDA receptor stimulation. Science 1999, 284:162-166.
111. Lee S.J., et al. Activation of CaMKII in single dendritic spines during long-term potentiation. Nature 2009, 458:299-304.
112. Vorel S.R., et al. Relapse to cocaine-seeking after hippocampal theta burst stimulation. Science 2001, 292:1175-1178.
113. 2+-permeable AMPA receptors recruited by CaM-kinase I. J. Neurosci. 2010, 30:11565-11575.
114. Park M., et al. Plasticity-induced growth of dendritic spines by exocytic trafficking from recycling endosomes. Neuron 2006, 52:817-830.
115. Jourdain P., et al. Calcium/calmodulin-dependent protein kinase II contributes to activity-dependent filopodia growth and spine formation. J. Neurosci. 2003, 23:10645-10649.
116. Okamoto K., et al. The roles of CaMKII and F-actin in the structural plasticity of dendritic spines: a potential molecular identity of a synaptic tag?. Physiology (Bethesda) 2009, 24:357-366.
117. 2+/calmodulin-dependent protein kinase II activity by regulated interactions with N-methyl-D-aspartate receptor NR2B subunits and alpha-actinin. J. Biol. Chem. 2005, 280:39316-39323.
118. Ma X.M., et al. Kalirin-7 is required for synaptic structure and function. J. Neurosci. 2008, 28:12368-12382.
119. 2+/calmodulin-dependent protein kinase II and alpha-actinin-1 in a calcium-dependent manner. J. Neurosci. 2002, 22:7879-7891.
120. 2+/calmodulin-dependent protein kinase II upon downregulation of cyclin-dependent kinase 5-p35. J. Neurosci. Res. 2006, 84:747-754.
121. Norrholm S.D., et al. Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5. Neuroscience 2003, 116:19-22.
122. Colbran R.J. Targeting of calcium/calmodulin-dependent protein kinase II. Biochem. J. 2004, 378:1-16.
123. Lisman J.E., Zhabotinsky A.M. A model of synaptic memory: a CaMKII/PP1 switch that potentiates transmission by organizing an AMPA receptor anchoring assembly. Neuron 2001, 31:191-201.
124. Glantz L.A., Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch. Gen. Psychiatry 2000, 57:65-73.
125. Glantz L.A., Lewis D.A. Dendritic spine density in schizophrenia and depression. Arch. Gen. Psychiatry 2001, 58:203.
126. Comery T.A., et al. Abnormal dendritic spines in fragile X knockout mice: maturation and pruning deficits. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:5401-5404.
127. Maze I., et al. Essential role of the histone methyltransferase G9a in cocaine-induced plasticity. Science 2010, 327:213-216.